Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
about
Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolismHigh Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary TractEnzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions.Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation.Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
P2860
Q30478225-19C9A67C-F34A-4B71-BDCE-C93A43B5B0F0Q33763973-1BC194CD-A5A5-47E6-B653-905C5C8A8EEAQ33809605-7F9DBD32-CBEF-41D6-92CF-3E950EAE186EQ34382405-5B5F70F5-77A5-4DEB-8F73-8EB32DB00ED1Q34547656-024A810B-5BCC-4F2F-AF98-D355CF15D130Q35825211-D2D2D752-919D-470D-9591-B43D0773826EQ35988382-6F491938-49C5-449D-94BA-5B7DCECBCFD4Q36003283-9C437D7E-CB33-4367-87E2-9B9F7B14D467Q37277775-CFE3C071-2A9E-4D01-90C3-96E4A3063257Q37676762-54DB0406-BCA8-4106-8CA6-C4C507936B45Q57072939-4A347635-3E26-4CCE-9704-C98AFEBA662A
P2860
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@ast
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@en
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase
@nl
type
label
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@ast
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@en
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase
@nl
prefLabel
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@ast
Suppressed expression of type ...... ial hyperplasia and carcinoma.
@en
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase
@nl
P2093
P2860
P1476
Suppressed expression of type ...... rial hyperplasia and carcinoma
@en
P2093
Hsueh-Kung Lin
Joseph Azzarello
Kar-Ming Fung
Kathleen N Moore
Scott McMeekin
Vladislav Zakharov
P2860
P304
P577
2010-07-05T00:00:00Z